Letters to the Editor
We wish to correct a potential misunderstanding of our findings as described in the article, as communicated by Gary Owens, MD, in the Stakeholder Perspective, “Important Insights from Real-World Treatment Patterns and Outcomes for Varicose Veins,” an opinion piece related to our article.
To the Editor: The study by Roy and colleagues (June 2015) presented a model framework to estimate the costs of treatment for relapsed and/or refractory multiple myeloma. We believe the assumptions applied in the study, particularly those regarding duration of therapy, lead to erroneous conclusions.
Results 1 - 3 of 3